Ascendis Pharma A/S (ASND)

CIK 1612042 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ascendis Pharma A/S.

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002678
Oct 26, 20266-K0001193125-26-431901
Oct 16, 20266-K0001193125-26-423938
Oct 14, 20266-K0001193125-26-421789
Sep 29, 20266-K0001193125-26-407293
Sep 28, 202640001610717-26-000423
Sep 15, 20266-K0001193125-26-390874
Sep 15, 20266-K0001193125-26-390877
Sep 9, 202640001610717-26-000409
Sep 9, 20266-K0001193125-26-386434
Sep 9, 20266-K0001193125-26-386630
Sep 8, 20261440001964306-26-000432
Sep 3, 202640001610717-26-000395
Sep 2, 20261440001973379-26-000330
Aug 31, 20266-K0001193125-26-376733
Aug 18, 202640001610717-26-000360
Aug 13, 2026SCHEDULE 13G/A0001193125-26-349304
Aug 13, 20266-K0001612042-26-000016
Aug 13, 20266-K0001193125-26-348046
Aug 12, 20266-K0001193125-26-347172
Aug 6, 20266-K0001193125-26-337270
Jul 15, 20266-K0001193125-26-304903
Jun 30, 20266-K0001193125-26-290485
Jun 29, 20266-K0001193125-26-288414
Jun 17, 20266-K0001193125-26-274306